Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rosser

Showing results (111-120 of 501) with videos related to

Pageof 51
Sort By:
The Journal of Urology|January 17, 2013
Diagnostic Potential of Urinary <alpha>1-Antitrypsin and Apolipoprotein E in the Detection of Bladder CancerVirginia Urquidi, Steve Goodison, Charles J Rosser
Current Medicinal Chemistry|June 12, 2012
Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosisV Urquidi, C J Rosser, S Goodison
European Medical Journal. Urology|February 18, 2014
MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSISVirginia Urquidi, Charles J Rosser, Steve Goodison
Journal of Translational Medicine|May 3, 2017
On the brink of extinction: the future of translational physician-scientists in the United StatesHideki Furuya, Dean Brenner, Charles J Rosser
Molecular Diagnosis & Therapy|March 13, 2013
Bladder cancer detection and monitoring: assessment of urine- and blood-based marker testsSteve Goodison, Charles J Rosser, Virginia Urquidi
Biomarkers in Medicine|September 19, 2013
Urinary biomarkers of bladder cancer: an update and future perspectivesCharles J Rosser, Virginia Urquidi, Steve Goodison
Expert Review of Proteomics|October 9, 2009
Urinary proteomic profiling for diagnostic bladder cancer biomarkersSteve Goodison, Charles J Rosser, Virginia Urquidi
Thescientificworldjournal|September 7, 2004
VURD syndrome managed by pyelostomyCharles J Rosser, Sam Auringer, R Lawrence Kroovand
Cancer Detection and Prevention|April 15, 2005
PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancerMotoyoshi Tanaka, Charles J Rosser, H Barton Grossman
Family Medicine|July 1, 1991
Rubella research and the Rosser familyW Rosser, J Rosser, T Rosser, et al.
Pageof 51

Showing results (111-120 of 501) with videos related to

Sort By:
Pageof 51
The Journal of Urology|January 17, 2013
Diagnostic Potential of Urinary <alpha>1-Antitrypsin and Apolipoprotein E in the Detection of Bladder CancerVirginia Urquidi, Steve Goodison, Charles J Rosser
Current Medicinal Chemistry|June 12, 2012
Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosisV Urquidi, C J Rosser, S Goodison
European Medical Journal. Urology|February 18, 2014
MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSISVirginia Urquidi, Charles J Rosser, Steve Goodison
Journal of Translational Medicine|May 3, 2017
On the brink of extinction: the future of translational physician-scientists in the United StatesHideki Furuya, Dean Brenner, Charles J Rosser
Molecular Diagnosis & Therapy|March 13, 2013
Bladder cancer detection and monitoring: assessment of urine- and blood-based marker testsSteve Goodison, Charles J Rosser, Virginia Urquidi
Biomarkers in Medicine|September 19, 2013
Urinary biomarkers of bladder cancer: an update and future perspectivesCharles J Rosser, Virginia Urquidi, Steve Goodison
Expert Review of Proteomics|October 9, 2009
Urinary proteomic profiling for diagnostic bladder cancer biomarkersSteve Goodison, Charles J Rosser, Virginia Urquidi
Thescientificworldjournal|September 7, 2004
VURD syndrome managed by pyelostomyCharles J Rosser, Sam Auringer, R Lawrence Kroovand
Cancer Detection and Prevention|April 15, 2005
PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancerMotoyoshi Tanaka, Charles J Rosser, H Barton Grossman
Family Medicine|July 1, 1991
Rubella research and the Rosser familyW Rosser, J Rosser, T Rosser, et al.
Pageof 51